Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wagner, Jan
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)	Withdrawn	3	70	Europe, RoW	Ganaxolone, Placebo, Standard of care	Marinus Pharmaceuticals	Refractory Status Epilepticus	08/24	08/24
NCT06154837: A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease	Recruiting	1	130	Europe	GSK3862995B, Placebo	GlaxoSmithKline	Pulmonary Disease, Chronic Obstructive	04/26	04/26
NCT06281236: A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)	Suspended	1	24	Europe	Prednisolone, SPI-62	Sparrow Pharmaceuticals	Polymyalgia Rheumatica	04/25	04/25